Hemic and Lymphatic Diseases

607 trials 240 recruiting

Filter these 607 trials by phase, country and sponsor.

Open in Search →

A study to test how either a capsule or a tablet with NDec (Decitabine and Tetrahydrouridine) works in the body of healthy people Not authorised

2023-504582-22-00 Sickle Cell Disease 1
A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Not authorised

2024-519745-30-00 Immune Thrombocytopenia (ITP) 9
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Not authorised

2023-503634-50-00 Anemia in patients with chronic kidney disease on dialy 5
A phase II study evaluating the efficacy and safety of IMetelstat in Patients with HR myElodysplastic SyndromeS or AML failing HMA-based the… Not authorised

2022-500721-32-00 AML and MDS patients failing or being refractory to hyp 4
Accelerate Improvement in Multiple Myeloma for Newly Diagnosed Transplant-Eligible Patients (AugMMent) Pending

2025-523990-40-00 Newly diagnosed Multiple Myeloma in patients eligible f 5
Epcoritamab in Relapsed/Refractory Marginalzone Lymphoma - A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY (EPOS-1) Pending

2025-524879-23-00 Marginal Zone Lymphoma 4
Clinical trial investigating the efficacy of gilteritinib and chemotherapy treatment in patients with Acute myeloid leukemia Pending

2024-518617-25-00 newly diagnosed non-M3 FLT3-positive acute myeloid leuk 4
A Study to Evaluate how Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) wh… Pending

2024-519709-37-00 Paroxysmal nocturnal hemoglobinuria (PNH) 5
A Phase 2/3 Study in Adult and Adolescent Participants with SCD Pending

2023-508766-14-00 Sickle Cell Disease 10
A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911 Pending

2025-523355-59-00 Immune Thrombocytopenia, Hematopoietic Syndrome of Acut 2
A first-in-human, open-label, clinical study to assess the safety, tolerability, and activity of OT-C001 (amplified/activated allogenic natu… Pending

2024-511843-24-00 Relapsed/refractory (R/R) diffuse large B-cell lymphoma 1
Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell … Pending

2024-520326-11-00 Acute Myeloid Leukemia (AML) 4
A multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients: efficacy and microbiologi… Pending

2024-520336-14-00 Post-chemotherapy neutropenia with high risk of develop 5
A multicenter phase 2 study of Belantamab mafodotin and Mezigdomide in combination with a phase Ib Safety run in patients with relapsed mult… Pending

2025-520976-25-00 Relapsed/refractory multiple myeloma 4
Efficacy of an empirical treatment with Amoxicillin-clavulanate (AC) compared to the combination Amoxicillin-clavulanate and Ciprofloxacin (… Pending

2025-520995-24-00 Adult patients treated for haematological disorders, in 5
PREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiot… Pending

2025-521571-30-00 Young Adults and adults with R/R B-cell acute lymphobla 5
Efficacy of cell therapy with allo-MSCs in patients with gvhd resistant to ruxolitinib second line therapy: a Phase IIB Clinical Trial - MSC… Pending

2025-523448-10-00 Gvhd Resistant to ruxolitinib and steroids 4
Combination Therapy with Interferon-Alpha2a and Ruxolitinib in Newly Diagnosed Patients with Polycythemia Vera. A Danish Safety and Efficacy… Pending

2024-518216-39-00 Polycythemia 4
A study of cemsidomide and dexamethasone in subjects with relapsed or refractory multiple myeloma (r/r MM) Pending

2025-524181-26-00 relapsed/refractory multiple myeloma 4
Phase 2 Study of Momelotinib in Combination with Luspatercept in Participants with Transfusion Dependent Myelofibrosis. Pending

2024-518225-15-00 Myelofibrosis 4
Role in GVHD prophylaxis of Vitamin D in patients undergoing allogeneic transplantation of stem cells. Phase II Pilot Study Pending

2024-518738-97-00 haematologic condition who need staminal cells transpla 4
A single arm, open label, multicenter, single-dose, phase 2b clinical study evaluating efficacy and safety of gene therapy using autologous … Pending

2025-522160-32-00 transfusion-dependent beta-thalassemia 4
A phase 2 study of ianalumab in adults with primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) who … Pending

2024-518231-11-00 Immune thrombocytopenia (ITP) Warm autoimmune hemolyti 4
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending

2024-519298-21-00 Cancer-Associated Thrombosis (CAT). 5